Now, here is the fact which ought to rouse us to action: the average duration of the disease in these cured cases was nine months――_nine precious months_ in which that remaining thirty, or forty, per cent. might have been cured _if they had only been treated earlier_. Or, if they had been properly examined still earlier by a trained person, the disease could have been dealt with earlier with a still better chance of ultimate cure, and it is Dr C. H. Mayo who has said that there is no reason on earth why about ninety-five per cent. of all cases of cancer of the breast cannot be permanently cured. So far we have spoken in detail of cancer of the breast but, when we come to deal with cancer of the uterus, we shall find that the facts are almost exactly analogous, only that the results of indecision and delay are even more deplorable. We find that, by the time they come for treatment, about half the cases are quite incurable, and those which are operable are as a rule a great deal further advanced than those of cancer of the breast. In spite of this we find that out of two hundred consecutive cases no less than forty per cent. were cured; that is to say, had no recurrence within seven years. All the cases which were operated on had had quite definite symptoms for six months. In other words, the patient herself should have come for examination six months before she did, and if she had been examined in the course of a proper routine, the disease could have been discovered far earlier than was the case. Quite recently, a report of a series of cases has been published by Professor Faure, a distinguished French gynæcologist, which so exactly illustrates my views that perhaps I may be forgiven for making use of it. Faure cut ninety-six cases of cancer of the uterus and has divided them into good cases, mediocre cases and bad cases. It is significant that there were only twenty-one “good” cases, thirty-five “mediocre” cases and forty “bad” cases. The good cases are what I have called early cases, the mediocre cases correspond to moderately advanced cancer, and the bad cases to those which are on the border line between operability and non-operability. His total results approximate very nearly to most other published lists but their analysis is very significant. Of the good cases there was one operative death; of the remainder seventy-five per cent. were cured and twenty-five per cent. recurred. Of the mediocre cases there was an operative mortality of 8.57%. Of those surviving the operation 62.5% were cured and 37.5% recurred. In the bad cases there was a post-operative mortality of 22.5%: only six were cured and twenty-five recurred. That is to say, respectively, 19.35% were cured and 80.65% recurred. These figures tell their own tale.